Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Synagis Prescribers (US)

Articles with lock require a subscription to GLG News | Request a free trial
June 2, 2008
Big opportunity for Glaxo
Analysis of: GlaxoSmithKline given OK to sell bird-flu vaccine in Europe | www.bizjournals.com
Author: GLG Expert Contributor
-Glaxo's pre-pandemic flu vaccine is a double opportunity - a chance to contract now with multiple governments to supply a pre-pandemic vaccine as well as a natural segue to become their future supplier of actual pandemic flu vaccine (when developed).  -When pandemic flu hits, the race will be...
May 21, 2008
GSK gets there first (for a change)
Analysis of: EU Approves GSK's Pre-Pandemic Bird Flu Vaccine | www.medicalnewstoday.com
Author: GLG Expert Contributor
Glaxo's new pandemic flu vaccine was just approved for sale and use in the EU.  It has or is trying to establish contracts with multiple countries to supply stockpiles with values in the 100's of millions
May 20, 2008
Good Summary of Current Practices
Analysis of: Guidelines Issued for Treating Atopic Eczema in Children | www.medscape.com
Author: GLG Expert Contributor
This article summarizes in a concise format what most of us do anyway. Nonetheless, it is good to have the steps clearly spelled out.    
May 19, 2008
Not Likely a Big Deal
Analysis of: Analyst: $850M opportunity for Allscripts with merger | www.forbes.com
Author: GLG Expert Contributor
I'd go with the second analyst in the article, who points out the exosting product overlap between the two companies.
May 19, 2008
Might Be a Lesson Here....
Analysis of: Renal Failure Linked to Cosmetic Soft-Tissue Filler Injections | www.medscape.com
Author: GLG Expert Contributor
The major effect, I would hope, would be to keep people from using unlicensed practitioners to do unapproved procedures with inappropriate products.
May 13, 2008
Lily's impact likely minimal
Analysis of: FDA Approves Strattera® for Maintenance of ADHD in Children and Adolescents | newsroom.lilly.com
Author: GLG Expert Contributor
Strattera has been approved for "maintenance treatment" for ADHD, however this probably changes nothing for prescribers or patients.  Those who are on it will continue to take it, but no one will be changing to Strattera because of this new classification.
May 12, 2008
Will Not Meaningfully Change Prescribing Patterns
Analysis of: FDA Approves Strattera® for Maintenance of ADHD in Children and Adolescents | newsroom.lilly.com
Author: GLG Expert Contributor
While this is new data from an 18 month study, the common practice already is to "stick with what works." Thus, if a child is started on Strattera (or another ADHD medication) and has positive results, the physician will most likely continue that drug.
May 12, 2008
A New Non-stimulant Approach to ADHD?
Analysis of: Abbott Scientists Present A New Approach for Treating Attention-Deficit Hyperactivity Disorder | biz.yahoo.com
Author: GLG Expert Contributor
Although just a press release, the itself study is interesting. The attempt to modify the symptoms of ADHD by affecting neurotransmitter release or reuptake is not new, but this is an attempt to do so via a novel receptor pathway.
May 12, 2008
does straterra work?
Analysis of: FDA Approves Strattera® for Maintenance of ADHD in Children and Adolescents | newsroom.lilly.com
Author: GLG Expert Contributor
we really have had little luck with straterra in  our office.  Even at high  doses,  the drug rarely does the trick
May 12, 2008
merck does the work
Analysis of: FDA Approves ROTARIX(R) Rotavirus Vaccine | www.pipelinereview.com
Author: GLG Expert Contributor
the vaccines may be similar, but I'll stick with the Merck product

Previous Page : 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Next41 to 50 of 156

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-01T21:45:56.203